Is CDKN2A p.Arg112His (c.335G>A) pathogenic?

CDKN2A p.Arg112His (c.335G>A) is classified Uncertain significance in CDKN2A (ClinVar, Multiple submitters, 3 submitters; last evaluated 2023-11-14). AlphaMissense: likely benign (0.2973); Very rare (popmax 6.22e-05%); Associated with hereditary neoplastic syndrome.

What condition is associated with CDKN2A p.Arg112His (c.335G>A)?

CDKN2A p.Arg112His (c.335G>A) is associated with hereditary neoplastic syndrome, familial melanoma (ClinVar).

How common is CDKN2A p.Arg112His (c.335G>A) in the general population?

CDKN2A p.Arg112His (c.335G>A) is very rare (popmax 6.22e-05%) (gnomAD).

What do computational predictors say about CDKN2A p.Arg112His (c.335G>A)?

AlphaMissense predicts likely benign (score 0.2973) — an in-silico prediction, not a clinical call.

CDKN2A p.Arg112His

c.335G>A · rs587782797 · VCV142887

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.2973 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 6.22e-05%)

Missense predictors

1/2 damaging

AlphaMissense, SaProt · REVEL indeterminate

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.2973	likely benign
REVEL	0.405	indeterminate
SaProt	LLR -10.09	damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL is indeterminate.
Splicing
SpliceAI	<0.2	no splice effect predicted · four deltas, not one · how we know
Constraint at this position
Conservation	phyloP 2.6	GERP 2, phastCons 1
Regional constraint	o/e 1.13	unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic
Overall
CADD	23.0	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 6.22e-05%

Overall 6.22e-05% 1/1,606,934 alleles · very rare exomes 1/1,454,582 · genomes 0/152,352 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CDKN2A
Protein: p.Arg112His
Coding: c.335G>A
MANE Select: NM_000077
dbSNP: rs587782797
Type: single nucleotide variant
Location: chr9:21971024 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 112: a UniProt-annotated variant site (in cmm2); the 'disordered' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: familial melanoma

Similar variants

CDKN2A p.Arg112Gly Pathogenic/Likely pathogenic ★★ same residue
CDKN2A p.Arg112Cys Uncertain significance ★★ same residue
CDKN2A p.Arg112Leu Uncertain significance ★★ ⚠ same residue
CDKN2A p.Arg112Pro Uncertain significance ★ ⚠ same residue
CDKN2A p.Arg112Ser Uncertain significance ★ ⚠ same residue
CDKN2A p.Arg112_Leu113insArg Pathogenic ★★ same residue
CDKN2A c.150+1G>A Likely pathogenic ★★ same condition
CDKN2A c.150+2T>G Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-arg112his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown